Nahor Haddish-Berhane

4PUBLICATIONS
42CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 21, 2026
Development of the Weight-Tiered Q3W Regimen of Amivantamab in Combination With Carboplatin-Pemetrexed in EGFR-Mutated Non-Small Cell Lung Cancer.

|May 13, 2026
Talquetamab: Mechanism of Action, Clinical, and Translational Science.

|Jul 24, 2025
Recommended Phase II Doses of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma From MonumenTAL-1: Clinical Pharmacology Results.

Jue Gong, Jie Zhou, Dongfen Yuan

|Jun 10, 2024
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study.

Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim

Pageof 1

Frequent Collaborators

2 joint publications

Dongfen Yuan

2 joint publications

Jie Zhou

2 joint publications

Jue Gong

2 joint publications

Pamela L Clemens